Clinical enrollment Target pharmaceutical sponsors and CROs seeking faster, more reliable patient recruitment for complex trials. Patient IP’s rapid, automated matching of digital records to trial criteria and HIPAA-compliant analytics can reduce enrollment timelines and improve retention, offering a clear value prop for trials with stringent inclusion/exclusion criteria.

Feasibility and design Position as a tool for study design and feasibility testing. Highlight capabilities to simulate patient pools and inform protocol modeling, enabling sponsors to de-risk trials early and optimize eligibility criteria before site start-up.

Provider engagement Leverage adoption by proactive healthcare providers to expand access channels. Emphasize how Patient IP can engage patients more deeply and support physician-led patient identification, aligning with sites aiming to improve enrollment quality through better patient engagement.

Strategic partnerships Explore collaborations with data and analytics firms, EHR/healthcare data aggregators, and networks like Clinerion to expand data sources, enhance matching accuracy, and accelerate time-to-enrollment for multi-site or global trials.

Commercial positioning Demonstrate cost efficiencies and ROI with a platform that supports rapid screening, reduced screen failures, and potential shortening of trial timelines. Target mid-market to larger CROs and pharma sponsors who operate high-volume, rapid-cycle studies.